PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Expanded Access IND Cleared by US FDA, page-13

  1. 1,041 Posts.
    lightbulb Created with Sketch. 31
    I never said that PPS had been tested on a scale equivalent to a phase 3 trial.

    https://www.ncbi.nlm.nih.gov/m/pubmed/24678076/

    Opportunity for you to do some further research.

    Spoiler: one of the investigators in this trial has been affiliated with PAR but I don’t think that’s any secret
    .

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.